Gentronix partners to add cell health assays for early research
Gentronix has added cell health assays through a partnership with BioQuanta to detect toxicity earlier in development.
Archives for November 2, 2011
Lonza’s CMO biz gains pegged back by higher raw materials costs for ingredients unit
Gains made in manufacturing, particularly in biologics, were pegged back by the impact raw materials costs and the strong Franc had on its ingredients division says Lonza.
News from BIO, Natrix, Amarantus and 3M – People on the move
in-PharmaTechnologist presents its round-up of the latest appointments in the pharmaceutical industry, including news from BIO, Natrix, Amarantus and 3M.
Obama pushes FDA and drugmakers to solve shortages
US President Barack Obama has leaned on the US FDA to ramp up its early warning system for drug shortages and asked manufacturers to do more.
Icon and Parexel earnings down on Pfizer deal hiring spree
Pfizer booked $340m with Icon and Parexel in the last quarter but profits dropped as the CROs hired 800 people to handle the work.
Evonik to buy SurModics’ drug delivery assets and cGMP plant
SurModics is selling its drug delivery assets and cGMP manufacturing facility to Evonik for $30m (€22m) in cash.
Chiral surfaces could cut manufacturing costs, say researchers
Using chiral metal surfaces in drug manufacturing could save companies time and money, say researchers at University of Cambridge.